www.BIRDFLU-MANUAL.com
PANDEMIC PREPAREDNESS FOR BUSINESSES
PANDEMIC PREPAREDNESS FOR BUSINESSES
BIRD FLU CHARACTERISTICS
|
High demand items. Secure yours now. (Warning: Please note we are finding it increasingly difficult to find suppliers for these items)
Tamiflu for your staff and families Don’t rely on Government and hospital supplies. There won't be enough. Secure your order here. Relenza - The Tamiflu alternative Evidence is emerging of Tamiflu resistent pandemic flu strains. Hedge your bets and get Relenza here. Alpha Pro Tech N-95 Face Masks Manufacturers can't keep up as the cheap ones don't work. Get your N-95s here. |
|
FREE Influenza Pandemic Preparedness email eCourse. Get Your Certificate! Join our free pandemic preparedness and planning email eCourse program. Leave your name and email and we’ll take you, one step at a time, through your pandemic preparedness activities, plus give you TWO eBooks on pandemic planning and response for the home. Get a certificate too! To learn more and enroll yourself please click here. |
Avian Flu pandemic will not be like a physical disaster. Avian Flu has unique characteristics when compared with a more "typical" disaster. For example:
The impact of Avian Flu would likely be widespread, not localised to a single area or region; therefore there may be little outside assistance. Many business continuity plans assume some part of an organisation is unaffected and can take up the required capacity.
An Avian Flu pandemic is not a physical disaster. It has some unique characteristics that require implementation of activities to limit contact such as restriction of movement, quarantine, and closure of public gatherings.
An Avian Flu pandemic would not be a short, sharp event leading immediately to commencement of a recovery phase. Many business continuity plans assume the event is short/sharp and that recovery can start immediately.
It is quite likely that there will be some advance warning from the development of Avian Flu, but it is always possible that any warning period may be very short. Should Avian Flu spread within SE Asia it will probably be some weeks before the full impact on workforce will be felt, although there may be some early impacts resulting from closures of schools and similar containment measures.
Unlike natural disasters, where any disruption to business service provision is likely to be hardware-related, disruption to business operation in the event of a pandemic is anticipated to be mainly human-resource oriented. WHO advises that businesses should plan for up to 50% staff absences for periods of about two weeks at the height of a severe pandemic wave, and lower levels of staff absence for a few weeks either side of the peak. Overall a pandemic wave may last about 8 weeks. Note that the pandemic may come in waves of varying severity over time.
Staff absences can be expected for many reasons:
• Illness/incapacity (suspected / actual / post-infectious)
• Some employees may need to stay at home to care for the ill
• People will feel safer at home (e.g. to keep out of crowded places such as public transport)
• Some people may be fulfilling other voluntary emergency roles in the community
• Others may need to stay at home to look after school-aged children (as schools are likely to be closed).
• An Avian Flu pandemic could last many months and may contain peaks followed by periods of reduced illness. The 50% is an estimate of staff absences at peaks of a significant pandemic.
Avian Flu may have other impacts on businesses, for example:
• Supplies of materials needed for ongoing activity may be disrupted, e.g. if they are imported as air freight; similarly, availability of services from sub-contractors may be impacted (this may affect maintenance of key equipment, and is an area that merits close planning attention).
• Demand for services may be impacted - demand for some services may increase (internet access is a possible example); while demand for others may fall (e.g. certain types of travel activity may reduce).
• Business continuity plans may need to be reviewed to ensure that they are robust to significant staff absences and other pandemic-related risks.
It is not possible to predict how long an Avian Flu pandemic may last. There could be more than one wave of infection during a pandemic period. Each wave could typically last about eight weeks, building to a peak in week four before abating again. The World Health Organiation advises that businesses should plan for up to 50% staff absences for periods of about two weeks at the height of a pandemic wave and lower levels of staff absence for a few weeks either side of the peak.
To ensure business continuity in a pandemic, short term planning, with a health focus, is paramount. Succession planning (in the event of staff deaths or long-term disability during the pandemic) and back up planning is also essential. Emergency management and overall recovery is greatly facilitated if essential services are available without significant interruption.
Continuity planning for Avian Flu should include:
• Identification of essential business activities (and the core people and skills to keep them running), and ensuring that these are backed-up with alternative arrangements.
• Mitigation of business / economic disruptions, including possible shortages of supplies; and Minimising illness in workers and customers.
Medical Advisor
If your business does not already have one, it may be prudent to ensure that it has access to a medical practitioner for assistance and advice in the event of an Avian Flu pandemic.
Don’t rely on Government and hospital supplies. There won't be enough. Get yours here now.
 Serving you 24/7/365 |
Bird Flu Manual eShop and Templates Library "... saving you time and money ..." |
|
ONLINE'S OTHER TOPICS BELOW:
| 01/20/2010 09:00 PM |
| 1918 And 2009 H1N1 Flu Probably Not Spread By Birds |
|
The two strains of the H1N1 influenza virus responsible for the 1918 and 2009 global flu pandemics do not cause disease in birds. The results of the study, published in the February issue of the Journal of General Virology, also show it is unlikely that birds played a role in the spread of the H1N1 virus in these pandemics...
|
| 01/14/2010 05:00 PM |
| New Research Findings Can Improve Avian Flu Surveillance Programs |
|
Genetic analyses of avian influenza in wild birds can help pinpoint likely carrier species and geographic hot spots where Eurasian viruses would be most likely to enter North America, according to new U.S. Geological Survey research...
|
| 01/08/2010 06:00 PM |
| NexBio Initiates Phase II Trial Of DAS181 (Fludase(R)) For Treatment Of Influenza, Including Pandemic Influenza A(H1N1) |
|
NexBio, Inc. announced the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection. DAS181 is an investigational host-targeted drug candidate that blocks entry of influenza virus into cells of the respiratory tract...
|
| 01/07/2010 08:00 PM |
| Also In Global Health News: ART Access In Zimbabwe; Indonesia Bird Flu Deaths; Kenya Floods; Solomon Island Tsunami |
|
Zimbabwe Wants To Boost Access To ART By End Of 2010, Health Minister Says Zimbabwe's government plans work with international organizations to increase the number of people receiving anti-retroviral therapy (ART) to 300,000 by the end of the year, up from the 180,000 who currently get the drugs, Henry Madzorera, the country's health minister, said on Tues...
|
| 12/25/2009 04:00 PM |
| Compound Found To Safely Counter Deadly Bird Flu |
|
The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public-health officials awake at night. Now, however, a study published this week (Dec...
|
| 12/22/2009 06:00 PM |
| Compound Found To Safely Counter Deadly Bird Flu |
|
The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public health officials awake at night. Now, however, a study published this week (Dec...
|
| 12/22/2009 05:00 PM |
| Medicago Reports Positive Phase I Results For Its Avian Flu Pandemic Vaccine |
|
Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine")...
|
| 12/07/2009 06:00 PM |
| 'Rational Drug Design' Identifies Fragments Of FDA-Approved Drugs Relevant To Emerging Viruses |
|
A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies -- according to a present...
|
| 12/04/2009 07:00 PM |
| Transplant Infectious Disease Experts Provide Pandemic Guidance |
|
Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic...
|
| 11/17/2009 04:00 PM |
| Scientists Put Interactive Flu Tracking At Public's Fingertips |
|
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say...
|
| 11/02/2009 04:00 PM |
| Potential Downside Of Yearly Influenza Vaccination For Children |
|
An article published Online First and in the December edition of The Lancet Infectious Diseases discusses the benefits and disadvantages of vaccination for children against seasonal flu. It reports that infection with "seasonal" influenza A could in fact benefit children by giving them improved immunity against pandemic strains such as the current swine flu H1N1 strain...
|
| 10/26/2009 07:00 PM |
| News From The Journals Of The American Society For Microbiology |
|
Genes May Determine Susceptibility to H5N1 Avian Influenza A Virus Infection A new study found genetic variations in mice affect their susceptibility to and severity of H5N1 avian influenza A virus infection suggesting that humans who contract the virus may be genetically predisposed. The researchers from St...
|
| 10/22/2009 04:00 PM |
| Rice, UT-Austin Team Wins Stimulus Funds To Study Influenza A |
|
Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu...
|
| 10/15/2009 09:00 PM |
| Previous Flu Viruses Provided Some Immunity To Current Swine Flu, Study Shows |
|
University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years...
|
| 10/14/2009 05:00 PM |
| ImmuneRegen BioSciences(R) Initiates Homspera(R) Studies Against Global Influenza Threat |
|
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist...
|
| 10/09/2009 05:00 PM |
| Protecting Humans And Animals From Diseases In Wildlife |
|
Avian influenza (H5N1), rabies, plague, Bovine Spongiform Encephalopathy (BSE), and more recently swine flu (H1N1) are all examples of diseases that have made the leap from animals to humans...
|
| 10/06/2009 09:00 PM |
| News From Annals Of Internal Medicine, October 6, 2009 |
|
Early Releases: 1. Earlier H1N1 Vaccination Prevents More Deaths, Saves Health Care Costs A vaccine for H1N1 influenza is anticipated to become available this fall. With the amount and timing of vaccine release still in question, policy makers struggle to set priorities regarding who should be vaccinated when...
|
| 10/02/2009 06:00 PM |
| Medicago Begins Human Clinical Testing With Its Avian Flu Pandemic Vaccine |
|
Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has initiated a Phase I human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrolment is ongoing and vaccination has commenced...
|
| 08/28/2009 07:00 PM |
| H1N1 Flu In Turkeys May Spread |
|
The detection of an H1N1 virus in turkeys in Chile raises concern that poultry farms elsewhere in the world could also become infected with the pandemic flu virus currently circulating in humans, FAO said today. Chilean authorities reported on 20 August that the pandemic H1N1/2009 virus was present in turkeys in two farms near the seaport of Valparaiso, Chile...
|
| 08/28/2009 06:00 PM |
| Lakewood-Amedex Inc. To Develop Broad Spectrum Influenza Drug To Include H1N1 And H5N1 Type A Strains |
|
Lakewood-Amedex Inc...
|
